UPC May Stop 'Divisional Game' In Novo's Ozempic Clash
The Unified Patent Court has said it could stop Novo Nordisk from playing what Sandoz calls the "divisional game" during the pair's ongoing Ozempic dispute, signaling an intention to keep patent...To view the full article, register now.
Already a subscriber? Click here to view full article